As emerging longterm data on IL23 inhibitors reinforce their strong efficacy and favorable safety profile in inflammatory bowel disease IBD learn how this affects treatment selection and sequencing for patients with moderate to severe IBD
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedApr 22, 2026
-
Last day to claim creditApr 22, 2027 6 months left
-
Medscape, LLC From Pathways to Practice: Exploring IL-23 Inhibitors for Inflammatory Bowel Disease
-
Med Learning Group The Future Is Anti-Inflammatory: Redefining IBD Outcomes Through Targeting IL-23p19
-
Bonum Continuing Education +1 Through the Looking Glass: Seeing a Better Future in IBD (IL-23p19s & IBD Tweetorial)
-
Clinical Care Options, LLC (dba Decera Clinical Education) Keeping Up in IBD Care: Recent Advances in IBD Therapies
-
Clinical Care Options, LLC (dba Decera Clinical Education) Playing the Long Game: Improving Durable Control in IBD
-
Smart Patients +1 Survey Says: Aligning Early Advanced IBD Therapy With Patient Priorities
